Immunology and Microbiology
Insulin Sensitivity
100%
Somatomedin
100%
Insulin
50%
Blood Plasma
50%
Arm
50%
Protein Binding
50%
Glucose Metabolism
50%
Gluconeogenesis
50%
ELISA
50%
Insulin Release
50%
Somatomedin C
50%
Sample Size
50%
Glucose Transport
50%
Glucose Blood Level
50%
Peptides
50%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Humanin
100%
Growth Factors
20%
Insulin-like
20%
Insulin Sensitivity
13%
Diabetes Prevention Program
13%
Diabetes Risk
13%
Human Plasma
6%
Increasing Age
6%
High-risk Individuals
6%
Insulin-like Growth Factor Binding protein-3 (IGFBP-3)
6%
Lifestyle Modification
6%
Hepatic Glucose Production
6%
Blood Samples
6%
Disease-related Proteins
6%
Related Conditions
6%
Health Relevance
6%
Public Health Risk
6%
Diabetes
6%
Binding Protein
6%
Diabetes Outcomes
6%
Placebo
6%
Ancillary
6%
Glucose Uptake
6%
ELISA Assay
6%
Nested Case-control Study
6%
Metformin Therapy
6%
Blood Glucose
6%
Central Administration
6%
Type 2 Diabetes Risk
6%
Mitochondrial-derived Peptides
6%
Central Effects
6%
Impaired Glucose Tolerance
6%
Stored Blood
6%
Public Health
6%
Alzheimer's Disease
6%
Insulin Action
6%
Insulin Secretion
6%
Glucose Metabolism
6%
Incident Diabetes
6%
Peripheral Administration
6%
Highly Sensitive
6%
Large Sample Size
6%
High Risk
6%
Novel Therapeutic Targets
6%
Novel Biomarkers
6%
Mitochondrial DNA
6%
Promising Biomarkers
6%
Etiology
6%
Circulating Levels
6%
Age-related Illnesses
6%
Pathophysiology
6%
Pharmacology, Toxicology and Pharmaceutical Science
Humanin
100%
Maturity Onset Diabetes of the Young
100%
Biological Marker
20%
Somatomedin
13%
Diseases
13%
Binding Protein
6%
Metformin
6%
Enzyme-Linked Immunosorbent Assay
6%
Alzheimer's Disease
6%
Prospective Study
6%
Pathophysiology
6%
Impaired Glucose Tolerance
6%
Mitochondrial DNA
6%
Somatomedin C
6%
Placebo
6%